MedPath

Evaluate The Effect of Unani Medicine in The Management of Hirsutism in Polycystic Ovarian Disease

Phase 2
Conditions
Health Condition 1: L680- Hirsutism
Registration Number
CTRI/2024/05/066930
Lead Sponsor
Pg Department of Obstetrics and GynaecologyIlmul Qabalath wa AmrazeNiswan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient With Regular and Irregular Periods

-Obesity

-Hypothyroidism

Exclusion Criteria

-Pregnant Women

-Genetic Disorders Like Cushing Syndrome,Ware Wolf Syndrome

-Hypertrichosis

-Women With Systemic Illness Like Liver Disorders,Kidney Disorders,DM Etc

-Women With Allergic or Hypertensive to NSAIDS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Hormonal AssayTimepoint: Once in 3 Month,Pre and Post Test
Secondary Outcome Measures
NameTimeMethod
Reduction in Clinical Sign and Symptoms.Timepoint: At Baseline,2 weeks,4 weeks,8 weeks,12 weeks
© Copyright 2025. All Rights Reserved by MedPath